-+ 0.00%
-+ 0.00%
-+ 0.00%

Flyte Aviation Executes Letter of Intent to Sell Cardiology Assets

Barchart·11/04/2026 15:15:00
Listen to the news

FORT MILL, S.C., Nov. 4, 2026 /PRNewswire/ -- Flyte Aviation, Inc. (NYSE American: VJET) ("Flyte" or the "Company"), a technology-enabled private aviation company, today announced that it has executed a non-binding Letter of Intent (LOI) to sell its legacy subsidiary Catheter Precision's VIVO, LockeT and associated life sciences assets. The parties to the LOI target closing by year-end 2026.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.